0001415889-17-001421.txt : 20170822 0001415889-17-001421.hdr.sgml : 20170822 20170822161013 ACCESSION NUMBER: 0001415889-17-001421 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170822 DATE AS OF CHANGE: 20170822 EFFECTIVENESS DATE: 20170822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293292 FILM NUMBER: 171045276 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 D 1 primary_doc.xml X0708 D LIVE 0001411685 VistaGen Therapeutics, Inc. 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 650-577-3600 NEVADA None Excaliber Enterprises, Ltd. Corporation true Shawn K. Singh 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Jerrold D. Dotson 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer H. Ralph Snodgrass 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Jon S. Saxe 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Director Brian J. Underdown 343 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Director Jerry B. Gin 343 Allerton Ave. South San Francisco CA CALIFORNIA 94080 Director Mark A. Smith 343 Allerton Ave. South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2017-03-30 false true true false 0 1037750 1037750 0 false 0 14 0 0 0 VistaGen Therapeutics, Inc. /s/ Shawn K. Singh Shawn K. Singh Chief Executive Officer 2017-08-22